Skip to content

Omega-3 nutrient supplementation and inflammatory and metabolic markers in people with Obesity: a randomized, controlled, double-blind clinical study

Physiological dose DHA supplementation and inflammatory and metabolic markers in people with Obesity: a randomized, controlled, double-blind clinical study - DHA docosahexaenoic acid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-78w4k8c
Enrollment
Unknown
Registered
2024-06-05
Start date
2024-06-25
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity due to excess calories

Interventions

A double-blind randomized clinical trial will be carried out with participants with a BMI equal to or greater than 30 kg/m2 at the Nutrology Division (Metabolic Unit) of the Clinical Medicine Departme
SP6.051.227

Sponsors

Universidade de São Paulo
Lead Sponsor
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Female biological sex; male biological sex; age range between 18 and 59 years; BMI equal to or greater than 30 kg /m2 (indicating obesity); sedentary (practicing less than 150 minutes of moderate to vigorous aerobic activity per week)

Exclusion criteria

Exclusion criteria: Unstable weight (2kg in the last 6 months); previous history or evidence of diseases that compromise the absorption of nutrients; cognitive impairment, in a way that compromises the understanding and consequent acceptance of participation in the research; hypertension; pacemaker patients; being in the gestational period or menopause; having an irregular menstrual cycle; smokers; have a food allergy or debilitating disease(s) of the gastrointestinal tract or some type of impairment of nutrient absorption; drug addicts or those with a history of misuse; those who start a diet or a sporting discipline during the study; those who are using or who during the study need to use medication that compromises or biases the results of the study; non-adherence to the proposed treatment (intervention); denial or withdrawal

Design outcomes

Primary

MeasureTime frame
By analyzing the results, it will be possible to identify inflammatory and metabolic alterations in patients with obesity.

Secondary

MeasureTime frame
The results of this research could contribute to the identification of markers associated with inflammation resulting from obesity, making it possible to indicate new targets for professional behavior. In addition, if the correlations stipulated in the project are proven, it will be possible to draw up a targeted plan for monitoring cases of the disease, with a specialized focus on the patient, considering the individuality of the subject, and the clinical, hematological and biochemical alterations presented, thus aiming to increase the chance of a better prognosis of the disease.

Countries

Brazil

Contacts

Public ContactJulio Marchini

Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo

jsmarchini@fmrp.usp.br+55(016)33153375

Outcome results

None listed

Source: REBEC (via WHO ICTRP)